Product Information
PAROXETINE ER 37.5 MG TABLET is a generic product labeled by Modavar Pharmaceuticals LLC, priced at $0.4279 per EA under NDC 72241003122. Its NADAC has been published 149 times since Aug 23, 2023.
Strength
37.5 mg/1
Manufacturer
Modavar Pharmaceuticals LLCNDC
72241003122
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PAROXETINE HYDROCHLORIDE HEMIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA212645On Market Since
10/20/2021
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE ER 37.5 MG TABLET has been published 149 times since Aug 23, 2023, and over the history we have for it it has declined 38.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4279 per EA |
|---|---|
| All-time high | $0.9265 (Oct 11, 2023) |
| All-time low | $0.3671 (Nov 20, 2024) |
| 52-week high | $0.5530 |
| 52-week low | $0.4047 |
| Median price | $0.5057 |
| Average price | $0.5303 |
| Largest weekly change | -37.4% (Oct 18, 2023) |
| Weeks tracked | 149 |
| Tracking since | Aug 23, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PAROXETINE ER 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE ER 37.5 MG TABLET, manufactured by Modavar Pharmaceuticals LLC, is $0.4279 per EA (NDC 72241003122), effective Jun 24, 2026.
How has the price of PAROXETINE ER 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE ER 37.5 MG TABLET has declined 38.3%. It has been tracked across 149 weekly CMS publications since Aug 23, 2023.
What are the highest and lowest recorded NADAC prices for PAROXETINE ER 37.5 MG TABLET?
Since Aug 23, 2023, the NADAC for PAROXETINE ER 37.5 MG TABLET has ranged from a low of $0.3671 (Nov 20, 2024) to a high of $0.9265 (Oct 11, 2023), with a median of $0.5057 per EA.
Are there cheaper alternatives to PAROXETINE ER 37.5 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as PAROXETINE ER 37.5 MG TABLET, but none are currently priced below it.
Who manufactures PAROXETINE ER 37.5 MG TABLET?
PAROXETINE ER 37.5 MG TABLET (NDC 72241003122) is labeled by Modavar Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification